Accelerating development of malaria-eradicating drugs

TropIQ Health Sciences offers laboratory screening services for the discovery and development of drugs against malaria. TropIQ combines world-class parasitological expertise with state of the art drug discovery technologies. Through this combination, TropIQ is uniquely positioned to accelerate the development of malaria-eradicating drugs. The company was founded in 2011 as a spin-off of the Radboud University Nijmegen Medical Center in the Netherlands.